Clinical urine tests

Global In-Vitro Diagnostics (IVD) Market Report 2022: Introduction of Disease-Specific Biomarkers and Tests Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 18, 2023
Biotechnology, Health, Medical Devices, Hospital, Degenerative disease, Immunoassay, Infection, Hemostasis, HIV/AIDS, Clifton Springs Hospital & Clinic, POC, Microbiology, Nephrology, Government, IVD, Coagulation, Cardiology, Urine test strip, Diagnosis, Growth, Diabetes, Region, Prevalence, Patient, Data management, USD, Medical device, Clinical urine tests, Software, Hematology

The global in-vitro market is projected to reach USD 144.7 billion by 2027 from USD 115.8 billion in 2022, at a CAGR of 4.6%.

Key Points: 
  • The global in-vitro market is projected to reach USD 144.7 billion by 2027 from USD 115.8 billion in 2022, at a CAGR of 4.6%.
  • On the basis of product and service, the IVD market is segmented into reagents & kits, instruments, services, and data management software.
  • The reagents & kits segment accounted for the largest share of the IVD market in 2021.
  • Based on technology, the IVD market is segmented into immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, hematology, microbiology, coagulation & hemostasis, urinalysis, and other technologies.

Urinalysis Market is expected to generate a revenue of USD 3.04 Billion by 2028, Globally, at 7.7% CAGR: Verified Market Research®

Retrieved on: 
Wednesday, November 9, 2022
Diagnosis, Urine test strip, Diabetes, Kidney failure, Color, Viral Research and Diagnostic Laboratories, Pregnancy, CAGR, Market research, Roche Diagnostics, Urinary tract infection, Beckman Coulter, Geography, Clinical urine tests, Time-invariant system, Kidney, USD, Hospital, Urine, Siemens, Mindray, Incidence, Consumables, Product type, Siemens Healthineers, Prevalence, Research, Sysmex Corporation, Institute, Danaher Corporation, Medical device, Medical imaging

JERSEY CITY, N.J., Nov. 9, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Urinalysis Market" By Product Type (Consumables, Instruments), By Test Type (Biochemical Urinalysis, Sediment Urinalysis), By End User (Hospitals and Clinics, Diagnostic Laboratories), By Application (Disease Diagnosis, Pregnancy Tests), and By Geography.

Key Points: 
  • According to an extensive study conducted by Verified Industry Research on the Urinalysis Market, the market size was valued at USD 1.60 Billion in 2020 and is projected to reach USD 3.04 Billion by 2028, growing at a CAGR of 7.7% from 2021 to 2028.
  • Urinalysis is the laboratory process that is used for diagnosis and management of various diseases related to the kidney and urinary tract.
  • During the forecast period, increased testing for urinary tract infections is expected to drive the global market.
  • Verified Market Research has segmented the Global Urinalysis Market On the basis of Product Type, Test Type, End User, Application, and Geography.

Keystone Lab Announces In-House Testing for Urine Cultures and Urinalysis

Retrieved on: 
Friday, November 4, 2022
Growth, Multimedia, Keystone, Clinical urine tests, Pathology, Forensic toxicology, Organization, Bacteria, CLIA, Microscopy, Urine, Goal, Laboratory, Oil

This is possible because referencing out Urine Cultures to another laboratory delays the report by a full day.

Key Points: 
  • This is possible because referencing out Urine Cultures to another laboratory delays the report by a full day.
  • With Keystone bringing the urine cultures in-house, we will expand the testing catalog of reportable antibiotics for gram positive and gram negative bacteria.
  • Please contact Keystone laboratories for the full list of antibiotics that we have expanded our capabilities to in testing.
  • Keystone Laboratories, Inc. is a dual CAP-accredited and CLIA certified lab providing clinical and forensic toxicology testing services for more than 35 years.

QSM Diagnostics Builds Momentum Heading into Fourth Quarter

Retrieved on: 
Thursday, September 15, 2022
Infection, Workload, Clinical urine tests, Veterinarian, Review, CEO, Standard of care, Doctor of Philosophy, FREE, PETS, Animal, Culture, Pet

BOSTON, Sep. 15, 2022 /PRNewswire-PRWeb/ -- QSM Diagnostics, a diagnostic device and testing company that helps veterinarians improve their diagnoses and treatment plans, to provide better animal care and pet owner satisfaction, has been gaining steady traction in the pet tech space with the launch of several new mail-in test products and customer facing features. New Product Innovation Adding depth to their current mail-in testing product lineup, QSM Diagnostics recently added a Cat Urinalysis with Culture and Sensitivity Kit and Dog/Cat Fecal Kit to their FetchDx portfolio. These kits help veterinarians with home re-checks, are ideal for telehealth use, and are great for monitoring chronic conditions. The Cat Urinalysis with Reflex Culture and Sensitivity Kit

Key Points: 
  • Adding depth to their current mail-in testing product lineup, QSM Diagnostics recently added a Cat Urinalysis with Culture and Sensitivity Kit and Dog/Cat Fecal Kit to their FetchDx portfolio.
  • These kits help veterinarians with home re-checks, are ideal for telehealth use, and are great for monitoring chronic conditions.
  • The New Fecal Kit FetchDx Fecal Sample Kit Allows for:
    "It feels like we are really starting to hit our stride," says Ed Goluch, PhD, Founder and CEO of QSM Diagnostics.
  • QSM Diagnostics now offers FREE unlimited 24/7 access to licensed veterinarians through texting or video calling to assist pet owners with sample collection.

Companion Animal Diagnostics Market to Reach USD 6.88 Billion, Globally, by 2031 at 8.6% CAGR: Allied Market Research

Retrieved on: 
Wednesday, August 17, 2022
NCBI, Rabies virus, Zoonosis, Industry, Diagnosis, Population, Technology, Growth, Dog, Cat, Incidence, Prevalence, Income, Clinical urine tests, Conditional sentence, Skin, Awareness, Infection, CAGR, Severe acute respiratory syndrome coronavirus 2, Research, COVID-19, Molecular diagnostics, Animal, Health, Adoption, Medical device, Vaccine, Pet, Hematology, Virology, Parasitology, University, Bacteriology

PORTLAND, Ore., Aug. 17, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, 'Companion Animal Diagnostics Market By Technology (Clinical Biochemistry, Immunodiagnostics, Molecular Diagnostics, Hematology, Urinalysis, Others), By Application (Clinical Pathology, Bacteriology, Virology, Parasitology, Other Applications), By Animal Type (Dogs, Cats, Others), By End User (Diagnostic Labs, Veterinary Hospitals and Clinics, Point-Of-Care and In-House Testing, Research Institutes and Universities): Global Opportunity Analysis and Industry Forecast, 2021-2031.' According to the report, the global companion animal diagnostics industry was estimated at $2.99 billion in 2021, and is anticipated to hit $6.88 billion by 2031, registering a CAGR of 8.6% from 2022 to 2031. The report offers an explicit analysis of the changing market trends, top segments, key investment pockets, value chain, competitive scenario, and regional landscape. The market study is exclusively meant to help the readers with a complete valuation of industry analysis and trends.

Key Points: 
  • According to the report, the global companion animal diagnostics industry was estimated at $2.99 billion in 2021, and is anticipated to hit $6.88 billion by 2031, registering a CAGR of 8.6% from 2022 to 2031.
  • This factor had a positive impact on the global companion animal diagnostics market.
  • Based on technology, the clinical biochemistry segment held around one-third of the global companion animal diagnostics market revenue in 2021, and is expected to lead the trail by 2031.
  • By animal type, the dogs segment contributed to nearly half of the global companion animal diagnostics market share in 2021, and is expected to retain its dominance by 2031.

Companion Animal Diagnostics Market to Reach USD 6.88 Billion, Globally, by 2031 at 8.6% CAGR: Allied Market Research

Retrieved on: 
Wednesday, August 17, 2022
NCBI, Rabies virus, Zoonosis, Industry, Diagnosis, Population, Technology, Growth, Dog, Cat, Incidence, Prevalence, Income, Clinical urine tests, Conditional sentence, Skin, Awareness, Infection, CAGR, Severe acute respiratory syndrome coronavirus 2, Research, COVID-19, Molecular diagnostics, Animal, Health, Adoption, Medical device, Vaccine, Pet, Hematology, Virology, Parasitology, University, Bacteriology

PORTLAND, Ore., Aug. 17, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, 'Companion Animal Diagnostics Market By Technology (Clinical Biochemistry, Immunodiagnostics, Molecular Diagnostics, Hematology, Urinalysis, Others), By Application (Clinical Pathology, Bacteriology, Virology, Parasitology, Other Applications), By Animal Type (Dogs, Cats, Others), By End User (Diagnostic Labs, Veterinary Hospitals and Clinics, Point-Of-Care and In-House Testing, Research Institutes and Universities): Global Opportunity Analysis and Industry Forecast, 2021-2031.' According to the report, the global companion animal diagnostics industry was estimated at $2.99 billion in 2021, and is anticipated to hit $6.88 billion by 2031, registering a CAGR of 8.6% from 2022 to 2031. The report offers an explicit analysis of the changing market trends, top segments, key investment pockets, value chain, competitive scenario, and regional landscape. The market study is exclusively meant to help the readers with a complete valuation of industry analysis and trends.

Key Points: 
  • According to the report, the global companion animal diagnostics industry was estimated at $2.99 billion in 2021, and is anticipated to hit $6.88 billion by 2031, registering a CAGR of 8.6% from 2022 to 2031.
  • This factor had a positive impact on the global companion animal diagnostics market.
  • Based on technology, the clinical biochemistry segment held around one-third of the global companion animal diagnostics market revenue in 2021, and is expected to lead the trail by 2031.
  • By animal type, the dogs segment contributed to nearly half of the global companion animal diagnostics market share in 2021, and is expected to retain its dominance by 2031.

Companion Animal Diagnostics Market Worth $4.18 Billion by 2029 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

Retrieved on: 
Monday, July 25, 2022
Ethos, Dog, Laboratory, Conditional sentence, Diagnosis, Clinical Biochemistry, Cornell University College of Veterinary Medicine, Cat, Incidence, Zoonosis, Geography, POC, Shandong University, Technology, Veterinarian, Impact, PCR, Point, Diabetes, Molecular diagnostics, Type 1 diabetes, Income, CAGR, Infection, Growth, Degenerative disease, Automation, Prevalence, Government, Saliva, Health, COVID-19, PETS, Veterinary medicine, Clinical urine tests, End user, Hospital Insurance and Diagnostic Services Act, Software, Heart failure, HMC, Lists of countries and territories, Thermo Fisher Scientific, Milk, Feline leukemia virus, FELV, Awareness, Urine, Idexx Laboratories, Mother, Hospital, Adoption, Dirofilaria immitis, Animal, Vaccine, Pharmaceutical industry, Medical device, Hematology, Leukemia

Therefore, the increasing prevalence of diseases in animals generates demand for diagnostic testing kits, driving the growth of the companion animal diagnostics market.

Key Points: 
  • Therefore, the increasing prevalence of diseases in animals generates demand for diagnostic testing kits, driving the growth of the companion animal diagnostics market.
  • Based on products, in 2022, the consumables segment is estimated to account for the largest share of the companion animal diagnostics market.
  • Quick Buy Companion Animal DiagnosticsMarket Research Report: https://www.meticulousresearch.com/Checkout/10760166
    Based on technology, in 2022, the immunodiagnostics segment is estimated to account for the largest share of the companion animal diagnostics market.
  • Based on end user, in 2022, the diagnostic laboratories segment is estimated to account for the largest share of the companion animal diagnostics market.

Companion Animal Diagnostics Market Worth $4.18 Billion by 2029 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

Retrieved on: 
Monday, July 25, 2022
Ethos, Dog, Laboratory, Conditional sentence, Diagnosis, Clinical Biochemistry, Cornell University College of Veterinary Medicine, Cat, Incidence, Zoonosis, Geography, POC, Shandong University, Technology, Veterinarian, Impact, PCR, Point, Diabetes, Molecular diagnostics, Type 1 diabetes, Income, CAGR, Infection, Growth, Degenerative disease, Automation, Prevalence, Government, Saliva, Health, COVID-19, PETS, Veterinary medicine, Clinical urine tests, End user, Hospital Insurance and Diagnostic Services Act, Software, Heart failure, HMC, Lists of countries and territories, Thermo Fisher Scientific, Milk, Feline leukemia virus, FELV, Awareness, Urine, Idexx Laboratories, Mother, Hospital, Adoption, Dirofilaria immitis, Animal, Vaccine, Pharmaceutical industry, Medical device, Hematology, Leukemia

Therefore, the increasing prevalence of diseases in animals generates demand for diagnostic testing kits, driving the growth of the companion animal diagnostics market.

Key Points: 
  • Therefore, the increasing prevalence of diseases in animals generates demand for diagnostic testing kits, driving the growth of the companion animal diagnostics market.
  • Based on products, in 2022, the consumables segment is estimated to account for the largest share of the companion animal diagnostics market.
  • Quick Buy Companion Animal DiagnosticsMarket Research Report: https://www.meticulousresearch.com/Checkout/10760166
    Based on technology, in 2022, the immunodiagnostics segment is estimated to account for the largest share of the companion animal diagnostics market.
  • Based on end user, in 2022, the diagnostic laboratories segment is estimated to account for the largest share of the companion animal diagnostics market.

Autoimmune Disease Diagnostics Market to hit USD 2 billion by 2030, says Global Market Insights Inc.

Retrieved on: 
Wednesday, July 13, 2022
Technology, Prevalence, MicroRNA, Infection, CRP, NCBI, Abbott Laboratories, Gene expression, Autoimmune disease, Biotechnology, Incidence, Midsayap Diagnostic Center and Hospital, Leukemia, CBC, C-reactive protein, SLE, Anemia, Awareness, Degenerative disease, Patient satisfaction, Renewable energy, Patient, Diagnosis, Thermo Fisher Scientific, Lupus, Cell, Bio-Rad Laboratories, Hospital, Psoriasis, Research report, CAGR, Woman, Research, Adoption, Growth, Industry, Complete blood count, CDC, USD, Vaccine, Fine chemical, Clinical urine tests

SELBYVILLE, Del., July 13, 2022 /PRNewswire/ -- The autoimmune disease diagnostics market value is expected to surpass USD 2 billion by 2030, according to a new research report by Global Market Insights Inc.

Key Points: 
  • Systemic autoimmune disease segment is set to cross USD 618 million by 2030.
  • Some major findings of the autoimmune disease diagnostics market report include:
    Growing prevalence of autoimmune diseases will drive the market size.
  • China autoimmune disease diagnostics market is likely to witness 8.5% CAGR from 2022 to 2030.
  • Supportive government policies and increasing awareness regarding autoimmune disease diagnostics among people in China will augment the market outlook.

Global $98.2 Bn In-Vitro Diagnostics/IVD Market 2022-2026 by Product and Service, Technology, Application & End User - ResearchAndMarkets.com

Retrieved on: 
Monday, May 23, 2022
Biotechnology, Hospitals, Health, Oncology, Immunoassay, Diabetes, Microbiology, Hospital, Hemostasis, Conditional sentence, POC, Cardiology, Degenerative disease, Patient, Infection, Investment, Government, IVD, Coagulation, USD, Industry, Awareness, MDX, Adoption, Lists of diseases, Instrument, CAGR, HIV/AIDS, Acquisition, Growth, Prevalence, Cancer, Urine test strip, Data management, Medical device, Pharmaceutical industry, Hematology, Oncology, Technology, Nephrology, CNN International Europe/Middle East/Africa, Clinical urine tests

Also, the development of disease-specific markers and tests is expected to offer potential growth opportunities to market players in the coming years.

Key Points: 
  • Also, the development of disease-specific markers and tests is expected to offer potential growth opportunities to market players in the coming years.
  • However, the unfavorable reimbursement scenario is expected to restrain the growth of this market during the forecast period.
  • Based on product and service, the IVD market is segmented into reagents & kits, instruments, services, and data management software.
  • Based on the end user, the IVD market is segmented into hospital laboratories, clinical laboratories, academic institutes, POC (point-of-care) testing centers, patients, and other end users.